Disease-A-Month
Volume 53, Issue 4 , Pages 195-199 , April 2007

Introduction to Parkinson’s Disease

References 

  1. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of IPD: a clinical pathologic study of 100 cases. J Neurol Neurosurg Psych. 1992;55:181–184
  2. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of lewy body Parkinson’s disease. Neurology. 2001;57:1497–1499
  3. Sejvar JJ, HBaddad MB, Tierny BC, et al. Neurologic manifestations and outcome of West Nile virus infection. 2003;290:511–515
  4. Bennett DA, Bickett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996;334:71–76
  5. Rajput AH, Offord KP, Beard CM, et al. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol. 1984;16:278–282
  6. Papavasiliou PS, Cotzias GC, Duby S, et al. Levodopa in parkinsonism: Potentiation of central effects with a peripheral inhibitor. N Engl J Med. 1972;285:814
  7. Parkinson Study Group. Pramipexole versus levodopa as initial treatment for Parkinson’s disease: a randomized control trial. JAMA. 2000;284:1931–1938
  8. Rascol O, Brooks DJ, Korczyn AD, et al. A five year study of the incidence of dyskinesias in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. N Engl J Med. 2000;342:1484–1491

PII: S0011-5029(07)00034-X

doi: 10.1016/j.disamonth.2007.05.001

Disease-A-Month
Volume 53, Issue 4 , Pages 195-199 , April 2007

Article Tools